Rising sales of its proprietary electron-beam computed tomography scanner sent Imatron’s sales soaring during the second fiscal quarter of 2000. Revenue for the three months ending June 30 was $15.5 million, an increase of 87% over revenue of $8.3
Rising sales of its proprietary electron-beam computed tomography scanner sent Imatrons sales soaring during the second fiscal quarter of 2000. Revenue for the three months ending June 30 was $15.5 million, an increase of 87% over revenue of $8.3 million for the same period a year earlier, the company announced.
Net income for the same three-month period increased $3 million to $1 million, compared to a net loss of $1.9 million for the same period a year ago. Second-quarter revenue increased 37% and net income increased 321% over Imatrons first quarter, end March 31, 2000.
Imatron has shown rising sales of its scanners (which the company calls simply EBT) in the U.S. and abroad. The firm is investing in development of an international sales staff to increase business in Japan, China, Germany, and the Middle East (SCAN, 7/5/00).
The primary use of Imatron scanners has been to detect coronary artery calcium, a technique that has been called into question in a joint statement by the American College of Cardiology and the American Heart Association for the shortage of conclusive studies on its efficacy. Imatrons defenders, in turn, criticized the consensus paper.
So far, the controversy has not dampened Imatrons sales.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.